Toronto, Ontario–(Newsfile Corp. – September 15, 2026) – Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, is pleased to announce its participation in the upcoming 3rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel.
This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.
Brief Summary
Quantum BioPharma Ltd. is set to showcase its innovative biopharmaceutical solutions at the upcoming 3rd Annual ArcStone-Kingswood Growth Summit in Toronto. This important event will take place on September 16, 2026, providing a platform for industry leaders to discuss advancements in the treatment of neurodegenerative and metabolic disorders.
- Company: Quantum BioPharma Ltd. (NASDAQ: QNTM)
- Event: ArcStone-Kingswood Growth Summit 2026
- Date: September 16, 2026
- Location: Sheraton Center Toronto Hotel
Why it matters: Quantum BioPharma’s participation will highlight its commitment to developing therapies that address critical health issues.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.